6Kim K A, Park P W, Hong S J, et al. The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmaeodynamies of clopidogrel:a possinle mechanism for clopidogrei resistance [J1. Clin Pharmacol Ther,2008,84 (2) .- 236-242.
7Li X Q,Andersson T B, Ahlstrom M, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities [J. Drug Metab Dispos, 2004,32 (8) : 821-827.
8Cianciolo G, Feliciangeli G, Comai G, et al. Protonic pump inhibitors in kidney transplant patients., efficacy and safety[-J. Minerva Urol Nefrol, 2007,59 (2) . 207- 215.
10Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al.ESC Guide- lines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J].Eur Heart J,2012,33(20) :2 569.
